Brief: Spago Nanomedical Q2 Sales SEK 0
20/08/2026 07:01
BRIEF-Spago Nanomedical Q2 Sales SEK 0 Aug 20 (Reuters) - Spago Nanomedical Q2 operating expenses SEK -8.418 million.
- Q2 adjusted EPS SEK -0.01
- Q2 net income SEK -7.331 million
SPAGO — Spago Nanomedical AB (publ) News Story
0.000.00%
Last trade - 00:00- SEK35.29m
- SEK2.78m
- SEK0.44m